Related Experiment Video
Updated: May 15, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Body composition and lipodystrophy in prepubertal HIV-infected children
Cecilia Zanin Palchetti1, Rose Vega Patin, Aída de Fátima Thomé Barbosa Gouvêa
1Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, SP, Brazil.
Summary
This study explored lipodystrophy in HIV-infected children, finding that body composition changes indicated preclinical signs. Continuous assessment of these changes is recommended for early detection in pediatric HIV management.
Area of Science:
- Pediatric Infectious Diseases
- Human Immunodeficiency Virus (HIV) Research
- Body Composition Analysis
Background:
- HIV infection and its treatments can lead to metabolic complications like lipodystrophy.
- Early identification of lipodystrophy is crucial for managing long-term health in children with HIV.
Purpose of the Study:
- To identify lipodystrophy in prepubertal HIV-infected children.
- To assess the utility of anthropometric parameters and body composition measurements for detecting lipodystrophy.
Main Methods:
- A cross-sectional study of 40 prepubertal HIV-infected children.
- Measurements included BMI z-score, height-for-age z-score, skinfolds, circumferences, and dual-energy X-ray absorptiometry (DXA).
- Clinical signs of lipodystrophy were assessed by a clinician.
Main Results:
- 27.5% of children exhibited clinical lipodystrophy, and 70% had dyslipidemia.
- Trunk-to-arm and limb-to-trunk ratios were associated with lipodystrophy.
- Children with lipodystrophy showed short stature, elevated triglycerides, and lower HDL-cholesterol.
Conclusions:
- Skinfold and DXA measurements can indicate preclinical lipodystrophy in HIV-infected children.
- While specific cutoff points are undetermined, continuous monitoring of body composition is advised.
- Early detection of body composition changes aids in managing lipodystrophy in pediatric HIV care.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...